Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$24.12
-4.12%
Mkt Cap $683.41M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $10.00M | $10.84M | +8.44% | -$2.22 | -$4.01 | -80.63% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$1.01 | -$1.27 | -25.74% | — | — |
| Q3 2025 Jul 31, 2025 | — | — | — | -$2.69 | -$4.93 | -83.27% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.05 | -$0.04 | +20.00% | — | — |
| Q1 2025 Feb 13, 2025 | — | $54.09K | — | -$0.16 | -$0.11 | +31.25% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.11 | -$0.15 | -36.36% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.17 | -$0.16 | +5.88% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.16 | -$0.17 | -6.25% | — | — |
| Q1 2024 Mar 27, 2024 | — | $10.00K | — | -$0.15 | -$0.14 | +6.67% | — | — |
| Q4 2023 Nov 3, 2023 | — | — | — | -$0.14 | -$0.14 | +0.00% | — | — |
| Q3 2023 Aug 2, 2023 | $50.00K | — | — | -$0.18 | -$0.13 | +27.78% | — | — |
| Q2 2023 May 3, 2023 | — | — | — | -$0.17 | -$0.17 | +0.00% | — | — |
| Q1 2023 Mar 29, 2023 | — | $75 | — | -$0.17 | -$0.19 | -11.76% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.26 | -$0.16 | +38.46% | — | — |
| Q3 2022 Aug 3, 2022 | — | $75.00K | — | -$0.29 | -$0.25 | +13.79% | — | — |
| Q2 2022 Apr 28, 2022 | — | — | — | -$0.31 | -$0.28 | +9.68% | — | — |
| Q1 2022 Mar 3, 2022 | — | $18.00K | — | -$0.31 | -$0.33 | -6.45% | — | — |
| Q4 2021 Nov 2, 2021 | $81.15K | $86.56K | +6.67% | -$0.32 | -$0.34 | -6.25% | — | — |
| Q3 2021 Aug 5, 2021 | $155 | $142 | -8.39% | -$0.31 | -$0.28 | +9.68% | — | — |
| Q2 2021 May 3, 2021 | $1.19M | $1.06M | -11.11% | -$0.32 | -$0.28 | +12.50% | — | — |